Business Wire

CA-VELODYNE-LIDAR

10.2.2021 12:50:05 CET | Business Wire | Press release

Share
Velodyne Lidar Signs Five-Year Sales Agreement with ThorDrive

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a five-year sales agreement to provide Ultra Puck™ sensors to ThorDrive, an autonomous technology company. ThorDrive is using Velodyne’s lidar sensors to power its cargo and baggage ground support tractors in a groundbreaking autonomous vehicle (AV) program at the Cincinnati / Northern Kentucky International Airport (CVG).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210210005224/en/

ThorDrive AVs, equipped with multiple Velodyne Ultra Puck sensors, were developed live in complex, safety-critical environments at CVG’s gates. Their proof of concept aims to advance airport safety and cargo efficiencies, with units to be sold by the end of 2021. In 2019, CVG, the 7th largest cargo airport in North America, handled over 1.2 million tons of cargo and baggage for more than 9.1 million passengers. By utilizing ThorDrive’s solution, airlines are able to autonomously transport baggage and cargo to and from planes and throughout facilities at any time, day or night. Safe, effective materials transit is critical to airlines for the protection and handling of goods while maintaining tight flight schedules.

ThorDrive chose Ultra Puck for its cargo transit vans because the sensor’s patented 3D surround view technology provides real-time object detection needed for safe, efficient navigation and dependable operation. Equipped with Velodyne’s lidar solutions, ThorDrive AVs use existing infrastructure and can operate in harsh weather conditions including rain, snow and ice, day and night. ThorDrive has been using Velodyne lidar sensors in developing its autonomous driving technology since 2010. ThorDrive is planning to expand its AV solutions further into the aviation ground support equipment market as well as to industrial and manufacturing applications.

“Our innovation partnerships focus on long-term viability and scale,” said Brian Cobb, Chief Innovation Officer for the Cincinnati / Northern Kentucky International Airport. “This agreement is a hallmark event towards ThorDrive’s capacity to scale up with Velodyne’s advanced sensor technology.”

“Velodyne is our trusted, long term partner to deliver high quality, reliable sensors at an affordable price point,” said Edward Shelton, VP of Business Development, ThorDrive. “Our software is tuned to their sensors’ state-of-the-art capabilities, advancing our efforts in providing transformative solutions for airline logistics and future applications of our autonomous technology. In working with Velodyne as the industry leader, we will be able to realize the future of moving cargo, equipment and materials.”

“We are thrilled to work with ThorDrive as they deliver trailblazing AV cargo transit programs to airports in North America and around the world, advancing safety and efficiency,” said Laura Wrisley, VP of North American Sales, Velodyne Lidar. “They have been on the forefront of innovation for delivery and logistics and we are proud to work with them along the way. ThorDrive AVs show that Velodyne’s lidar sensors provide the range and field of view needed to gain visibility in complex environments to detect and avoid obstacles for safe logistics transport.”

About Velodyne Lidar

Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne is the first public pure-play lidar company and is known worldwide for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com .

About ThorDrive

ThorDrive is a full-stack developer of autonomous driving technology for the aviation, industrial and tier 1 automotive markets. With operations in South Korea and headquarters in Cincinnati, Ohio, ThorDrive has developed autonomous solutions for the safe and efficient movement of materials, cargo, baggage and people since 2016. Through industry, manufacturing and customer partnerships, ThorDrive’s main focus is to proliferate their autonomous solutions in industries and with customers that are driven to develop and implement technologies that enhance safety while maintaining a competitive edge. For more information, visit www.thordrive.ai .

Forward Looking Statements

This press release contains "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, competition. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," “can,” "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include Velodyne's ability to manage growth; Velodyne's ability to execute its business plan; uncertainties related to the ability of Velodyne's customers to commercialize their products and the ultimate market acceptance of these products; the uncertain impact of the COVID-19 pandemic on Velodyne's and its customers' businesses; uncertainties related to Velodyne's estimates of the size of the markets for its products; uncertainties regarding government regulation and adoption of lidar for pedestrian safety, traffic congestion and smart city applications; the rate and degree of market acceptance of Velodyne's products; the success of other competing lidar and sensor-related products and services that exist or may become available; Velodyne's ability to identify and integrate acquisitions; uncertainties related to Velodyne's current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne's intellectual property; and general economic and market conditions impacting demand for Velodyne's products and services. Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Link:

ClickThru

Social Media:

https://www.facebook.com/VelodyneLidar/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye